News
LXRX
1.560
-2.50%
-0.040
Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)
TipRanks · 2d ago
Needham Keeps Their Hold Rating on Lexicon Pharmaceuticals (LXRX)
TipRanks · 2d ago
Needham Reiterates Hold on Lexicon Pharmaceuticals
Benzinga · 2d ago
U.S. RESEARCH ROUNDUP-Blackline, Medpace Holdings, Roblox
Wall Street analysts revise ratings and price targets on several U.S.-listed companies. Airbnb, Medpace Holdings, Roblox and Intel among those with revised targets. Airbnb raises target price to $150 from $145. JP Morgan adds stock to its focus list.
Reuters · 2d ago
LEXICON PHARMACEUTICALS INC <LXRX.O>: JEFFERIES CUTS TARGET PRICE TO $2 FROM $2.5
Reuters · 2d ago
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Shares of Matterport, Inc. Rose sharply during Monday's session. The Nasdaq Composite gained over 100 points on Monday. Matterport shares climbed 184% to $4.93. Graphjet Technology's stock surged 27.6% amid a rise in Bitcoin. Other big stocks recording gains in today's session include MicroStrategy and Sea Limited.
Benzinga · 3d ago
Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers
Healthcare On the Move: Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers. S&P 500 Health Care Sector +0.08% to 1620.1. Moolec Science SA, NKGen Biotech, ProKidney among top gainers.
Seeking Alpha · 3d ago
Weekly Report: what happened at LXRX last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at LXRX last week (0408-0412)?
Weekly Report · 04/15 09:22
Needham Sticks to Its Hold Rating for Lexicon Pharmaceuticals (LXRX)
TipRanks · 04/11 10:28
Needham Reiterates Hold on Lexicon Pharmaceuticals
Benzinga · 04/11 10:20
Weekly Report: what happened at LXRX last week (0401-0405)?
Weekly Report · 04/08 09:23
Weekly Report: what happened at LXRX last week (0325-0329)?
Weekly Report · 04/01 09:23
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
LuxUrban Hotels shares dipped 27.4% to $1.5523 on Wednesday. The company issued preliminary fourth-quarter revenue outlook below estimates. MariaDB plc shares climbed 70.4%. Lixte Biotechnology Holdings, Inc. Shares jumped 68.6% in mid-day session.
Benzinga · 03/27 17:06
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
Shares of Cintas Corporation jumped 9.7% to $694.62 on Wednesday. The company reported better-than-expected third-quarter financial results and raised FY24 guidance. PaySign, Inc. Shares jumped 28.2% after the company announced better- than-expected fourth-quarter results. Dow Jones index gained around 300 points in Wednesday's session.
Benzinga · 03/27 14:03
WPRT, FIVN and FATE are among after hour movers
On the Move WPRT, FIVN and FATE are among after hour movers. Stoke Therapeutics (STOK) and AnaptysBio (ANAB) are among the Gainers. Westport Fuel Systems (WPRT) and Five9 (FIVN) are losers.
Seeking Alpha · 03/25 21:15
Lexicon Pharmaceuticals files to sell 57.66M shares for holders
Lexicon Pharmaceuticals files to sell 57.66M shares for holders Mar. 25, 2024. The company filed a prospectus related to the proposed resale of 57. 66M shares by selling stockholders. This prospectus is not an offer to sell these securities.
Seeking Alpha · 03/25 20:35
Lexicon Pharmaceuticals Announces Clinical Data On The Impact Of Sotagliflozin On Stroke And Heart Attack Risk Among Four Lexicon-Sponsored Presentations At The American College Of Cardiology 73rd Annual Scientific Session & Expo
Four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport proteins, will be delivered during the American College of Cardiology 73rd Annual Scientific Session & Expo in Atlanta, 2024. The presentations include results from a post-hoc evaluation of the efficacy of the drug in reducing stroke events in patients with type 2 diabetes, chronic kidney disease and high cardiovascular risk.
Benzinga · 03/25 13:25
Weekly Report: what happened at LXRX last week (0318-0322)?
Weekly Report · 03/25 09:23
Weekly Report: what happened at LXRX last week (0311-0315)?
Weekly Report · 03/18 09:23
More
Webull provides a variety of real-time LXRX stock news. You can receive the latest news about Lexicon Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About LXRX
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The Company pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. The Company is conducting preclinical development of LX9851, an orally delivered small molecule drug candidate, as a treatment for obesity and tool for weight management.